"Designing Growth Strategies is in our DNA"

Recombinant DNA Technology Market Size, Share and Global Trend By Product (Vaccines, Therapeutic Agents, Recombinant Protein, Others), By Component (Vectors, Expression System, Others), By Application (Diagnostics, Therapeutic, Food and Agriculture, Others), By End User (Biotechnology and Pharmaceutical Companies, Diagnostic Laboratories, Academic and Government Research Institutes, Other) and Regional Forecast, 2024-2032

Region : | Report ID: FBI101016 | Status : Ongoing



Recombinant DNA technology has successfully established its dominance in the vaccines and medicines. Recombinant DNA technology is also being used for the diagnosis of diseases by the developing radioactive probes and diagnostic kits. In medicines, recombinant DNA technology can be employed for the production of antibiotics, hormones like insulins, enzymes, interferons, and many others. Recombinant DNA technology involves the isolation of the desired gene and introducing it into a vector DNA to enable the synthesis of the desired gene on a large scale.

Other than medicine, recombinant DNA technology also has application in the production of genetically modified crops and animals. The advantages of recombinant DNA technology in the treatment of chronic diseases such as diabetes, cancer, and others. Growing investment in research for the development of recombinant products, which is anticipated to fuel the recombinant DNA technology market growth during the forecast period.

To gain extensive insights into the market, Request for Customization

Growing applications of recombinant DNA for the treatment of various diseases and the increased investment for research are the major factor responsible for the growth in recombinant DNA technology market. Apart from these, the rising trend of strategic mergers and acquisitions is also expected to boom the recombinant DNA technology market during the forecast period.

For example, in 2017, Sanofi Pasteur Inc., acquired Protein Sciences, which resulted in the addition of Flublok, an influenza vaccine into their product portfolio and strengthening both the position of Sanofi Pasteur Inc. as well as the global recombinant DNA technology market during the forecast period.

However, the ethical concerns and unknown outcomes of gene modifications are the factors that are likely to hamper the recombinant DNA technology market growth during the forecast period. 

Key Players Covered

Some of the major companies that are present in the global recombinant DNA technology market report include Novartis AG, Thermo Fisher Scientific Inc., Sanofi Pasteur Limited, Merck KGaA, Genentech Inc., GlaxoSmithKline plc., Eli Lilly and Company, Pfizer Inc., Janssen Pharmaceuticals Inc., and others.




By Product

· Vaccines

· Therapeutic Agents

· Recombinant Protein

· Others

By Component

· Vectors

· Expression System

· Others

By Application

· Diagnostics

· Therapeutic

· Food and Agriculture

· Others

By End User

· Biotechnology and Pharmaceutical Companies

· Diagnostic Laboratories

· Academic and Government Research Institutes

· Other

By Geography

· North America (U.S. and Canada)

· Europe (U.K., Germany, France, Italy, Spain, Scandinavia, and Rest of Europe)

· Asia Pacific (Japan, China, India, Australia, Southeast Asia, and Rest of Asia Pacific)

· Latin America (Brazil, Mexico, and Rest of Latin America)

· Middle East & Africa (South Africa, GCC, and Rest of Middle East & Africa)


In terms of application, diagnostic application segment is anticipated to hold a considerable share in global recombinant DNA technology market owing to the growing number of genetic disorders and various cancers globally, enhancing the demand for early detection of disease in order to receive effective treatment therapies.

Key Insights

  • Technological Advancements in recombinant DNA technologies

  • The Regulatory Scenario of Key Country/Region

  • Recent Key Industry Developments – Mergers, Acquisitions, And Partnerships.

Regional Analysis

The global recombinant DNA technologies market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is anticipated to dominate the recombinant DNA technology market owing to the increase in strategic collaborations among many key players and rising R&D investments. In 2017, Novartis AG received FDA approval for its product based on gene transfer named Mariah for acute lymphoblastic leukemia, which is more likely to boost the recombinant DNA technology market in North America. Recombinant DNA technology market is anticipated to expand at a significant rate during the forecast period owing to the growing patient pool, growing investments by many government organizations, and rising awareness about the application of recombinant DNA technology in various sectors. 

Global Recombinant DNA Technology Industry Developments

  • In July 2017, Sanofi Pasteur Limited acquired Protein Sciences, which resulted in addition of Flublok, an influenza vaccine into their product portfolio and strengthening both the position of Sanofi Pasteur Inc. as well as the global recombinant DNA technology market
  • In 2017, Novartis AG received FDA approval for its product based on gene transfer named Mariah for acute lymphoblastic leukemia,

  • Ongoing
  • 2023
  • 2019-2022

Personalize this Research

  • Granular Research on Specified Regions or Segments
  • Companies Profiled based on User Requirement
  • Broader Insights Pertaining to a Specific Segment or Region
  • Breaking Down Competitive Landscape as per Your Requirement
  • Other Specific Requirement on Customization
Request Customization Banner

Healthcare Clients

Siemens Healthineers

Client Testimonials

“This report is really well done and we really appreciate it! Again, I may have questions as we dig in deeper. Thanks again for some really good work.”

- U.S.-based biotechnology company focussing on treatment of chronic pain.

“Kudos to your team. Thank you very much for your support and agility to answer our questions.”

- Europe-based provider of solutions to automate data centre operations.

“We appreciate you and your team taking out time to share the report and data file with us, and we are grateful for the flexibility provided to modify the document as per request. This does help us in our business decision making. We would be pleased to work with you again, and hope to continue our business relationship long into the future.”

- India-based manufacturer of industrial and specialty intermediates with a strong global presence.

“I want to first congratulate you on the great work done on the Medical Platforms project. Thank you so much for all your efforts.”

- One of the largest cosmetics company in the world.

“Thank you very much. I really appreciate the work your team has done. I feel very comfortable recommending your services to some of the other startups that I’m working with, and will likely establish a good long partnership with you.”

- U.S. based startup operating in the cultivated meat market.

“We received the below report on the U.S. market from you. We were very satisfied with the report.”

- Global hearing aids manufacturer.

“I just finished my first pass-through of the report. Great work! Thank you!”

- U.S. based solar racking solutions provider.

“Thanks again for the great work on our last partnership. We are ramping up a new project to understand the imaging and imaging service and distribution market in the U.S.”

- World’s leading advisory firm.

“We feel positive about the results. Based on the presented results, we will do strategic review of this new information and might commission a detailed study on some of the modules included in the report after end of the year. Overall we are very satisfied and please pass on the praise to the team. Thank you for the co-operation!”

- Germany based machine construction company.

“Thank you very much for the very good report. I have another requirement on cutting tools, paper crafts and decorative items.”

- Japanese manufacturing company of stationery products.

“We are happy with the professionalism of your in-house research team as well as the quality of your research reports. Looking forward to work together on similar projects”

- One of the Leading Food Companies in Germany

“We appreciate the teamwork and efficiency for such an exhaustive and comprehensive report. The data offered to us was exactly what we were looking for. Thank you!”

- Intuitive Surgical

“I recommend Fortune Business Insights for their honesty and flexibility. Not only that they were very responsive and dealt with all my questions very quickly but they also responded honestly and flexibly to the detailed requests from us in preparing the research report. We value them as a research company worthy of building long-term relationships.”

- Major Food Company in Japan

“Well done Fortune Business Insights! The report covered all the points and was very detailed. Looking forward to work together in the future”

- Ziering Medical

“It has been a delightful experience working with you guys. Thank you Fortune Business Insights for your efforts and prompt response”

- Major Manufacturer of Precision Machine Parts in India

“I had a great experience working with Fortune Business Insights. The report was very accurate and as per my requirements. Very satisfied with the overall report as it has helped me to build strategies for my business”

- Hewlett-Packard

“This is regarding the recent report I bought from Fortune Business insights. Remarkable job and great efforts by your research team. I would also like to thank the back end team for offering a continuous support and stitching together a report that is so comprehensive and exhaustive”

- Global Management Consulting Firm

“Please pass on our sincere thanks to the whole team at Fortune Business Insights. This is a very good piece of work and will be very helpful to us going forward. We know where we will be getting business intelligence from in the future.”

- UK-based Start-up in the Medical Devices Sector

“Thank you for sending the market report and data. It looks quite comprehensive and the data is exactly what I was looking for. I appreciate the timeliness and responsiveness of you and your team.”

- One of the Largest Companies in the Defence Industry
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . Privacy.